Lifechart, a rising gut wellness brand, has successfully raised $500,000 in a seed funding round aimed at expanding its AI capabilities and launching innovative gut health solutions. The round was led by Prajay Advisors LLP, which invested $250,000, with additional contributions from Agility Ventures, Expert Dojo, and a group of angel investors, including Ahana Gautam, Nitish Mittersain, Sarath Sura, and Marwari Angels, through convertible instruments.
Founded in 2022 by Mukul Shah and Mansi Sharma, Lifechart seeks to address the growing gut health issues in India by leveraging AI-driven predictive technology and products created by qualified BAMS and BHMS doctors. This recent seed round follows the company’s $200,000 pre-seed funding in 2022 from Expert Dojo and Nazara Technologies’ Nitish Mittersain.
The new capital will help Lifechart introduce proprietary diagnostic solutions, enhance its AI-driven platform, and expand its presence in tier 1 cities. The brand is also planning to launch a range of plant-based, microbiome-focused products, alongside comprehensive wellness kits aimed at addressing common gut issues such as constipation, fatty liver, piles, gas, and acidity.
Lifechart has already reached over 250,000 customers, primarily in tier II, III, and IV cities. With the global gut health market projected to reach $18 billion by 2025-26, Lifechart is positioning itself to capture a significant share through its personalized and innovative offerings tailored to specific demographic and regional health patterns.
